U.S.U.S. National
Overton's nomination withdrawal means no clear end for FDA leadership vacuum
The Hill

The White House's abrupt withdrawal of Heidi Overton as President Trump's nominee to lead the Food and Drug Administration (FDA) means the agency will remain without stable leadership six months after the former...
This is a brief preview. The complete story is published by The Hill.
Read full story at The HillOpens thehill.com
Headline, excerpt, and image © The Hill. Open Wire Media indexes public feeds and links to the original publisher.